Member Info for moonparty

Scancell are obliged to pass on the information to the market in a timely manner whenever they are notified of director buys or sells. They can't hold the information and release a single RNS.

Actually a repeat of last Monday won't be a spike to 50p, it will be a rapid rise to 50p and the share price staying at close to that level :)

https://amp.theguardian.com/society/2021/feb/21/scientists-say-clinical-trials-for-variant-proof-vaccines-could-start-very-soon

Same as published elsewhere, but the Guardian!We may have a repeat of last Monday tomorrow, in which case we could spike to 50p. IMO.

Wildforce, absolutely!
The first patient dosed RNS will lead to a price increase on the day, and the following days once the media picks it up.
It is hard to predict the impact of such publicity , but we could easily surge to over £1 (IMO), but we should be there already right, with all the pipelines that Scancell has?
It's hard to justify a market cap below £1 Billion.
All in my opinion

the market makers will approach known large holders to release some shares. Not saying this is what has happened, but it could be.
Basically, if there is strong demand but no supply the market will halt and nobody gains, so supply has to be found somewhere! MMs can effectively halt a market by putting tight limits on the amount you can buy and sell and widening the bid/offer spread to put people off trading.
The same is true in reverse - if everybody is selling an nobody buying the market will effectively halt.

And Scancell have been working on the basis of the vaccine (moditope, avidimab) for years, nay decades!

https://news.sky.com/story/covid-19-new-vaccine-in-development-has-insurance-against-virus-mutations-12217119

Apologies if already posted, only saw a link that leads to this one. The Sky News one is arguably more important for sp impact.

If anyone is watching Sky News channel can you report back if this is on telly as well?

This is awesome, expecting a big blue day tomorrow.

Wonder if my girlfriend would mind if I ask Lindy to be my valentine ?!!?

Happy to report II purchase of Calidus via II worked very nicely.

Oh, and it's in a stable country. Very important for miners!

Thanks pinecone, but the gambler in me prefers a more geared investment than physical gold or the equivalent.
I think gold is likely to rise in the next couple of years (at the very least it's a hedge against my other investments) and I like Calidus because:
- provides a geared play on gold (as do all miners)
- re-rating highly likely as they get closer to production
- potential for further growth from new tenements and further exploration on existing tenements
- the management, so far, seem very able to stick to timetables and do good deals.

Thanks pinecone too!

Thanks Chirpy, will look forward to checking tomorrow morning :)

About the markets at the moment, and I have cash in my SIPP, so I have decided more exposure to gold would be a good thing.
I know of no finer gold investment than Calidus! So I've put in a limit order with II - has anyone else traded Calidus with II?
My order was accepted online, but no idea if they will be efficient at executing it, especially as Australia opening times are completely outside UK office 9 - 5.

The companies quoted are NOT peers to Angle - they are companies much further down the road with actual revenue / profits. There tech may or may not be as good, but it is, as we speak, more commercially successful.

Consider me biased as I have sold some of my holding, but there is risk here.
It is not guaranteed to go up at all when FDA approval is announced. Ever head of "sell the news"?
Angle has a great product, and I think it has a high chance of success, but lets be sensible - nothing is guaranteed.
It is a one product company. A good solid product, but there is inherent risk in this.
It has had a good run and is now valued at £200 Million. Is potential success factored in here? And is the discount enough to cover the risk of failure? It's not easy to do the maths with a start-up, as there is lots of guess work on market size, market penetration etc.. etc.. Each to their own, but there seems to be a lot of people thinking this is a one way ticket to riches. Please be sensible.

yesterday. Watch it move to £1 now, lol.
Just think the FDA approval is priced in to some extent now. Had a good run from an average in the 40s though.

Profits moved into Scancell (SCLP) - another bio with awesome technology.

Good luck to all holders here, may get back in closer to April depending on price!

Time for take off?

Wow! Tech like that, if successful, could be worth multiple billions on it's own!
More left-field news to come?
Sooner or later something will get commercialised - law of averages!

They would have to build up a position on the market, as Scancell don't need new funds. Could be interesting...

Oh to be able to predict the timing of sp moving news :)

Short answer: IMO, yes, plenty of news _could_ drop

Actual answer: I don't know, not does anybody else that is trading this share, else it would be illegal insider trading.

From a quick google, there is definitely interest in the scientific community in the N protein, but I can't find any other vaccine targets directly targeting it. Will look more thoroughly this evening. If anyone else is aware of other vaccines targeting the N protein, please post. I'm sure there are many in development, but I think/ho[e covidity is ahead of the pack?